NinePoint Medical Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 65

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

  • Investors
  • 2

NinePoint Medical General Information

Description

Developer of a real-time pathology device designed to offer vivo imaging to create quality products that improve patient care. The company's device can be used as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by offering two-dimensional and cross-sectional depth visualization, enabling physicians to make an accurate diagnosis and effective therapy for their patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 12 Oak Park Drive
  • Bedford, MA 01730
  • United States
+1 (617)
Primary Industry
Diagnostic Equipment
Vertical(s)
TMT
Corporate Office
  • 12 Oak Park Drive
  • Bedford, MA 01730
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NinePoint Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Bankruptcy: Admin/Reorg 16-Oct-2020 Completed Bankruptcy: Admin/Reorg
10. Grant 21-Apr-2020 Completed Generating Revenue
9. Grant 15-Mar-2019 Completed Generating Revenue
8. Debt Repayment 01-Apr-2018 Completed Generating Revenue
7. Later Stage VC (Series C) 25-Nov-2015 Completed Generating Revenue
6. Debt - General 09-Feb-2015 Completed Generating Revenue
5. Later Stage VC (Series B) 20-Mar-2014 Completed Generating Revenue
4. Debt - General 31-Mar-2013 Completed Generating Revenue
3. Grant 03-Nov-2010 $250K $33M Completed Startup
2. Early Stage VC (Series A) 14-Oct-2010 $33M $33M Completed Startup
To view NinePoint Medical’s complete valuation and funding history, request access »

NinePoint Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A1 30,819,616 $0.010000 $0.05 $0.6 $0.6 $0.6
Series A 15,200,000 $0.010000 $0.08 $1 $1 $1
To view NinePoint Medical’s complete cap table history, request access »

NinePoint Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a real-time pathology device designed to offer vivo imaging to create quality products that improve patient
Diagnostic Equipment
Bedford, MA
65 As of 2016

Charlotte, NC
 

Tokyo, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NinePoint Medical Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sonablate Private Equity-Backed Charlotte, NC
PENTAX Medical Corporation Tokyo, Japan
Insightec Venture Capital-Backed Tirat Carmel, Israel
KARL STORZ Corporation Tuttlingen, Germany
Guerbet Group Corporation Villepinte, France
You’re viewing 5 of 16 competitors. Get the full list »

NinePoint Medical Patents

NinePoint Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4069085-A1 Enclosed imaging apparatus and method for use thereof Pending 06-Dec-2019
US-20210169314-A1 Enclosed imaging apparatus and method for use thereof Pending 06-Dec-2019
EP-4069085-A4 Enclosed imaging apparatus and method for use thereof Pending 06-Dec-2019
EP-3634247-A2 Imaging apparatus with tissue retrieval channel Pending 06-May-2017
US-20180317773-A1 Imaging apparatus with tissue retrieval channel Pending 06-May-2017 A61B5/0066
To view NinePoint Medical’s complete patent history, request access »

NinePoint Medical Board Members (10)

Name Representing Role Since
Eric Swanson Self Board Member
You’re viewing 1 of 10 board members. Get the full list »

NinePoint Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NinePoint Medical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hercules Capital Lender/Debt Provider
Monroe Capital Lender/Debt Provider
To view NinePoint Medical’s complete investors history, request access »

NinePoint Medical FAQs

  • When was NinePoint Medical founded?

    NinePoint Medical was founded in 2008.

  • Who is the founder of NinePoint Medical?

    Eman Namati Ph.D is the founder of NinePoint Medical.

  • Where is NinePoint Medical headquartered?

    NinePoint Medical is headquartered in Bedford, MA.

  • What is the size of NinePoint Medical?

    NinePoint Medical has 65 total employees.

  • What industry is NinePoint Medical in?

    NinePoint Medical’s primary industry is Diagnostic Equipment.

  • Is NinePoint Medical a private or public company?

    NinePoint Medical is a Private company.

  • What is NinePoint Medical’s current revenue?

    The current revenue for NinePoint Medical is .

  • How much funding has NinePoint Medical raised over time?

    NinePoint Medical has raised $110M.

  • Who are NinePoint Medical’s investors?

    Hercules Capital and Monroe Capital have invested in NinePoint Medical.

  • Who are NinePoint Medical’s competitors?

    Sonablate, PENTAX Medical, Insightec, KARL STORZ, and Guerbet Group are some of the 16 competitors of NinePoint Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »